We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+4.75%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$12.2B
AUM Growth
-$389M
(-3.1%)
Cap. Flow
-$619M
Cap. Flow
% of AUM
-5.09%
Top 10 Holdings %
Top 10 Hldgs %
12.87%
Holding
355
New
13
Increased
118
Reduced
193
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$41.6M |
| 2 |
Universal Display
OLED
|
+$39.4M |
| 3 |
Martin Marietta Materials
MLM
|
+$37.2M |
| 4 |
A.O. Smith
AOS
|
+$31.8M |
| 5 |
Edwards Lifesciences
EW
|
+$31.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$85.9M |
| 2 |
Perrigo
PRGO
|
+$73.9M |
| 3 |
QLGC
QLOGIC CORP
QLGC
|
+$50.1M |
| 4 |
Bath & Body Works
BBWI
|
+$42.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.43% |
| 2 | Industrials | 19.54% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMSG
276
DELISTED
Amsurg Corp
AMSG
| $3.5M | 0.03% |
45,206
-8,870
| -16% | -$686K |
|
277
Pacira BioSciences
PCRX
$1.06B
| $3.45M | 0.03% |
102,244
-63,218
| -38% | -$3.11M |
|
|
ITCI
278
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.18M | 0.03% |
81,999
-111,615
| -58% | -$4.01M |
|
|
SGMO
279
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.98M | 0.02% |
513,930
-313,637
| -38% | -$2M |
|
|
BLUE
280
DELISTED
bluebird bio
BLUE
| $2.65M | 0.02% |
4,717
-2,439
| -34% | -$1.38M |
|
|
CFMS
281
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2.61M | 0.02% |
+14,858
| New | +$3.49M |
|
282
Precigen
PGEN
$2.12B
| $2.23M | 0.02% |
91,617
-404,996
| -82% | -$11.5M |
|
283
Broadcom
AVGO
$1.85T
| $1.96M | 0.02% |
125,780
-12,180
| -9% | -$186K |
|
284
UnitedHealth
UNH
$383B
| $1.7M | 0.01% |
12,045
-1,161
| -9% | -$155K |
|
|
MDCO
285
DELISTED
Medicines Co
MDCO
| $1.7M | 0.01% |
50,529
-9,895
| -16% | -$349K |
|
286
Alphabet (Google) Class C
GOOG
$4.08T
| $1.44M | 0.01% |
41,660
-3,900
| -9% | -$140K |
|
287
Cognizant
CTSH
$24.3B
| $1.36M | 0.01% |
23,777
-2,284
| -9% | -$138K |
|
288
Bristol-Myers Squibb
BMY
$132B
| $1.28M | 0.01% |
17,402
-1,669
| -9% | -$118K |
|
289
TJX Companies
TJX
$176B
| $1.27M | 0.01% |
32,800
-7,576
| -19% | -$289K |
|
290
Apple
AAPL
$4.9T
| $1.15M | 0.01% |
48,056
-11,480
| -19% | -$285K |
|
291
Blackrock
BLK
$170B
| $1.12M | 0.01% |
3,274
-322
| -9% | -$113K |
|
|
AGN
292
DELISTED
Allergan plc
AGN
| $992K | 0.01% |
4,292
-415
| -9% | -$95.7K |
|
293
Oracle
ORCL
$367B
| $932K | 0.01% |
22,774
-2,199
| -9% | -$87.8K |
|
294
American International
AIG
$41.8B
| $896K | 0.01% |
16,932
-1,622
| -9% | -$89.5K |
|
295
JPMorgan Chase
JPM
$933B
| $896K | 0.01% |
14,426
-1,381
| -9% | -$86.3K |
|
296
Biogen
BIIB
$30.7B
| $833K | 0.01% |
3,446
-331
| -9% | -$87.2K |
|
|
GWR
297
DELISTED
Genesee & Wyoming Inc.
GWR
| $683K | 0.01% |
11,591
-1,117
| -9% | -$68.4K |
|
298
Teva Pharmaceuticals
TEVA
$41.2B
| $612K | 0.01% |
12,186
-1,167
| -9% | -$62.1K |
|
|
GNC
299
DELISTED
GNC Holdings, Inc.
GNC
| $538K | ﹤0.01% |
22,148
+686
| +3% | +$19K |
|
|
300
Perrigo
PRGO
$1.43B
| $298K | ﹤0.01% |
4,679
-713,477
| -99% | -$73.9M |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Frontier Capital Management held 355 positions worth $12.2B, down 3.1% from $12.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management withdrew a net $619M in Q2 2016, closing 16 positions and reducing 193 holdings. Its most notable exit was Hologic, an estimated $34M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.
Against the trend, Frontier Capital Management opened a new position in Align Technology worth $31.3M.
- Frontier Capital Management's largest Q2 2016 buy was Align Technology: 388,528 shares worth $31.3M.
- Frontier Capital Management added most to Beacon Roofing Supply, Inc. in Q2 2016, an estimated $41.6M increase.
- Frontier Capital Management's biggest Q2 2016 reduction was American Airlines Group, cutting an estimated $85.9M.
- Frontier Capital Management fully exited Hologic in Q2 2016, selling an estimated $34M.
- Frontier Capital Management's ten largest holdings make up 13% of its $12.2B portfolio in Q2 2016.
- Frontier Capital Management opened 13 new positions and closed 16 in Q2 2016.
- Frontier Capital Management's portfolio value fell 3.1% quarter-over-quarter to $12.2B.
Based on Frontier Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.